4-Antibody
Latest round
- Series A
Last raised
- Jan 2007
Total raised
- $19M
Investors
- 6
About 4-Antibody
4-Antibody AG is a biotechnology firm based in Basel, Switzerland, dedicated to developing antibody therapeutics. The company was acquired in February 2014 by Antigenics, a portfolio company of Deutsche Bank and various investment firms. The acquisition details were not disclosed.4-Antibody AG specializes in the discovery and development of immuno-oncology therapeutics. Their core products include antibody therapies aimed at enhancing the immune system's capacity to fight cancer, with a specific focus on combination therapies utilizing various modalities. The company’s lead product, botensilimab, is designed to improve efficacy and tolerability for patients with microsatellite stable colorectal cancer (MSS CRC), addressing significant medical needs within oncology.4-Antibody AG generates revenue primarily through partnerships and collaborations with industry leaders that facilitate their clinical-stage programs. Their revenue model involves B2B transactions, including upfront payments, milestone payments, and royalties from the sales of proprietary products.4-Antibody AG is focused on developing new antibody-based products targeting various cancers, with specific plans for expansion into international markets, particularly North America and Europe. Following the acquisition in February 2014, the company continues to align its strategies to leverage its capabilities in immuno-oncology, while aiming for broader market reach and partnerships.
Who invested in 4-Antibody
6 investors across 2 rounds
See all investors in 4-Antibody
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 4-Antibody
Who invested in 4-Antibody?
4-Antibody has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 4-Antibody raised?
4-Antibody has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did 4-Antibody last raise money?
4-Antibody's most recent round on record is a Series A, in Jan 2007.
What does 4-Antibody do?
4-Antibody AG is a biotechnology firm based in Basel, Switzerland, dedicated to developing antibody therapeutics.
Where is 4-Antibody headquartered?
4-Antibody is headquartered in Basel, Switzerland.
Which VCs invest in companies like 4-Antibody?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at 4-Antibody's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like 4-Antibody? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.